拉巴提尼布通过调节SPP1表达来促进肝瘤细胞的亡
Dang Wang1,2, Keyi Jiang1,2, Hongqi Feng3,2
1Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, Heilongjiang 150081, China.
Anti-cancer agents in medicinal chemistry
|February 10, 2026
概括
分泌的蛋白1 (SPP1) 在肝肝细胞癌 (LIHC) 中升高,与预后不佳有关. 向药物lapatinib通过减少SPP1表达和促进细胞亡来抑制LIHC细胞的生长.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝肝细胞癌 (LIHC) 是一个重要的全球健康问题.
- 针对性治疗的精确机制,如LIHC中的拉帕提尼布,需要进一步阐明.
- 分泌蛋白1 (SPP1) 涉及各种癌症,但其在LIHC中的作用尚未完全理解.
研究的目的:
- 研究SPP1在LIHC进展和患者预后中的作用.
- 探索拉帕提尼布对LIHC中SPP1表达的抗瘤作用.
- 阐明拉帕提尼布在LIHC中发挥作用的分子机制.
主要方法:
- 对LIHC中SPP1表达的癌症基因组图谱 (TCGA) 和GSE6764数据集的分析.
- 评估SPP1表达及其与患者生存结果的相关性.
- 使用HepG2细胞进行体外研究,以评估拉帕提尼布对SPP1水平,细胞增殖 (CCK-8试验) 和细胞亡 (BAX/Bcl2比率的西方抹杀) 的影响.
主要成果:
- 与正常肝脏组织相比,LIHC组织中的SPP1表达显著更高 (P <0.01).
- 升高的SPP1水平与LIHC中较差的患者生存结果相关 (P <0.05).
- 拉巴提尼布治疗减少了SPP1的表达,抑制了HepG2细胞的增殖,增加了BAX/Bcl2比率,并诱导了亡.
结论:
- 在LIHC患者中,SPP1是疾病进展和生存的潜在生物标志物.
- 拉帕提尼布通过降低SPP1表达的调节,在LIHC中显示出抗瘤活性.
- 拉帕提尼布促进肝瘤细胞的亡,有助于其在LIHC中的治疗效果.
相关概念视频
Regulation of Expression Occurs at Multiple Steps
26.5K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
26.5K
Regulation of Expression Occurs at Multiple Steps
4.0K
4.0K
The Eukaryotic Promoter Region
18.9K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.9K
Regulation of Expression at Multiple Steps
1.4K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.4K
Constitutive and Regulated Gene Expression
1.3K
Gene expression in prokaryotes is governed by constitutive and regulated systems, allowing cells to balance the production of essential proteins with adaptive responses to environmental changes.Constitutive Gene ExpressionConstitutive, or housekeeping, genes are continuously expressed as they encode proteins vital for fundamental cellular processes. These include enzymes for glycolysis, ribosomal components for protein synthesis, and proteins involved in DNA replication. Their constant...
1.3K
Apoptosis
15.2K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
15.2K


